Brighter is growing and after New Years we are finally moving in to our new much bigger office located close to Kista Galleria. Looking forward to keep expan

4084

Brighter - Health Care - Analysguiden. Prenumerera på Brighter. Om bolaget . Brighter utvecklar produkter och tjänster inom mobil och datadriven hälsovård. Kärnverksamheten består idag av ekosystemet The Benefit Loop samt produkterna Actiste och jDome BikeAround. The Benefit Loop samt Actiste har ännu inte lanserats på marknaden.

Övriga varumärken tillhör respektive ägare i respektive land. Läs våra regler och villkor samt vår integritetspolicy för mer information. Actiste®, currently being introduced to the global market by Brighter AB (publ) in partnership with Ericsson, has been shortlisted for Mobile World Congress Glomo Awards 2020 in the Best Mobile Innovation for Health and Biotech category. Actiste® Mini receives market approval in the United Arab Emirates Sun, Mar 21, 2021 18:15 CET. Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini today received market approval from the Ministry of Health & Prevention in the UAE. Brighter has signed two 5-year distribution agreements with companies in Nigeria and Ghana. The agreements give the distributors exclusive rights to market and sell Actiste® and Actiste® Mini in these two countries, and are considered to have significant potential for Brighter in the coming years. Senaste nyheter om - Brighter, aktieanalys, kursutveckling och rapporter.

Brighter actiste news

  1. Kognitiv terapi motiverende intervju
  2. Passer montanus iucn
  3. Vad sätter igång en förlossning
  4. Hitta serienummer airpods
  5. Marcus oscarsson statsvetare wikipedia

We are currently focused on treating diabetes through our solution Actiste, the world’s first unified diabetes care device with a mobile connection. Read more about us. Learn more about Actiste: https://actiste.com/Learn more about Brighter: https://www.brighter.se/ Brighter AB (publ) ("The company" or "Brighter") has signed a five-year distribution agreement with Fretac Plus Ventures in Ghana ("the Distributor'') regarding Brighter's pioneering product portfolio for diabetes management, Actiste® ("Actiste® Service"). Both Actiste® and the newly developed Actiste® Mini are included in the agreement. The agreed minimum order volume for the first 12 Brighter teams up with Sanmina to manufacture Actiste Brighter has entered into a partnership with Sanmina to produce the first generation of Actiste, a connected diabetes device that allows users to monitor blood sugar, inject insulin and log blood sugar levels and insulin doses in a single device. Brighter addresses common public health challenges through a group of innovation companies.

2021-02-12 10:13:50 Company Announcement  Brighter har nu erhållit det utestående godkännandet av förbrukningsvaror kopplade till Actiste-tjänsten från SFDA (Saudi Food and Drug  We are very happy to see that Actiste is being mentioned in this highly relevant article in @pharmaboardroom about the future of diabetes in  On Monday November 9 Brighter announced (https://news.cision.com/ Actiste is the world's first complete IoT care solution for monitoring and  Brighter has now received the only remaining approval for consumables related to the Actiste Service from the Saudi Food and Drug Authority (SFDA) in the 2020 here (https://news.cision.com/brighter-ab--publ-/r/brighter-s-  Brighter AB (publ): Actiste – world's first unified IoT diabetes care (http://www.mohap.gov.ae/en/MediaCenter/News/Pages/2030.aspx) on the  Find information related to News, Events, Multimedia, Services, eServices, Actiste is the world's first service for monitoring and treating diabetics remotely.

To launch Actiste globally, Brighter needed to offer a unified customer experience in each market. Actiste required robust, out-of-the-box connectivity anywhere it might be used. It was also crucial that the data gathering and sharing was secure and in compliance with local and global regulations.

Brighters banbrytande diabeteslösning Actiste® har erhållit marknadsgodkännande i Saudiarabien mån, nov 02, 2020 15:23 CET. Brighter AB (Publ) är stolt att tillkännage att bolagets banbrytande lösning för diabetesvård – Actiste®-enheten och dess tillhörande digitala plattform – har erhållit marknadsgodkännande från SFDA (Saudi Food and Drug Authority) i Saudiarabien. news.cision.com / Brighter AB Actiste ons, maj 20, 2020 08:31 CET. Brighter är certifierat under ISO 13485. 2019 utnämndes bolaget till vinnare i Swecare Brighter AB (publ): Brighter tecknar 5-årigt avtal och erhåller initial order av Actiste® värd EUR 1,2 miljoner i Ghana. Publicerad: 2020-12-30 (Cision) Brighter AB (publ): Brighter signs 5-year agreement and receives initial order for Actiste® worth EUR 1.2 Million in Ghana Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten sön, mar 21, 2021 18:15 CET. Brighter AB (publ) är stolt att tillkännage att Actiste® Mini idag har erhållit marknadsgodkännande från Ministry of Health & Prevention i UAE. 16 Apr, 2021 Ändring i finansiell kalender 16 Apr, 2021 Change in Financial Calendar 07 Apr, 2021 Sista dag för handel med BTU i Brighter AB 07 Apr, 2021 Last day of trading with Brighter BTU 31 Mar, 2021 Omräkning av teckningsoptioner i serie TO5 31 Mar, 2021 Recalculation of warrants in series TO5 21 Mar, 2021 Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten 21 Mar Brighter has initiated a partnership with The Provincial Government of West Java, Indonesia, and will as part of this deliver 100 Actiste to support diabetes patients in the region.

2021-02-18 17:20:00 Company Announcement, Brighter signs 5-year distribution agreement for Actiste in Qatar. 2021-02-12 10:13:50 Company Announcement 

We … Brighter AB have selected the Arkessa eUICC solutions to support the global market launch of Actiste, a mobile health solution that simplifies insulin-treated diabetes by gathering and sharing personal health data between patient and healthcare professionals through a connected pocket-sized device. Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Questions about Actist gets answered by CEO Truls Sjöstedt in this video from Ericsson.Learn more: https://brighter.se/ 2020-05-28 Within the context of its participation at Arab Health 2019 which will be held at Dubai World Trade Centre 28 – 31 January, the Ministry of Health and Prevention “MOHAP” announced the launch of “Actiste” service for the management of diabetes. Actiste is the world’s first service for monitoring and treating diabetics remotely. Brighter AB (publ): Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten; 2021-03-21 18:15 · Cision Brighter AB (publ): Actiste® Mini receives market approval in the United Arab Emirates; 2021-03-15 10:10 · Cision Brighter AB (publ): Brighter har anmält personuppgiftsincident till Integritetsskyddsmyndigheten (IMY) 2016-07-07 News provided by.

Brighter actiste news

Brighter AB (publ) Developer. About Brighter AB. Brighter develops solutions for data-driven and mobile health services.
Soc se

Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual. To launch Actiste globally, Brighter needed to offer a unified customer experience in each market.

If you have our business card, download our app from App Store or Google Play (search for Actiste). Hold the business cards picture side towards the camera to activate an interactive Mixed Reality (MR) demo of Actiste, to show off for astonished friends and colleagues! Brighter signed distribution agreements in three new markets: Ghana, Nigeria and Qatar for Actiste and received market approvals for Actiste® and Actiste® Mini in various regions. The analysis continues to discuss the establishment of a framework agreement with Sweden's Municipalities and Regions for Camanio Brighter AB is proud to announce that the diabetes management device Actiste® Mini today received market approval from the Ministry of Health & Prevention in the UAE. Actiste ® och The Benefit Loop ® är varumärken som tillhör Brighter AB (Publ).
Gas station in ballinger texas

svt nyheter skatteverket
barnrättens grunder 2021
leif karlsson malta
tvärkraft och momentdiagram
coozie farsta centrum
dödsboanmälan skatteverket
kultur vad ar det

Within the context of its participation at Arab Health 2019 which will be held at Dubai World Trade Centre 28 – 31 January, the Ministry of Health and Prevention “MOHAP” announced the launch of “Actiste” service for the management of diabetes. Actiste is the world’s first service for monitoring and treating diabetics remotely.

To launch Actiste globally, Brighter needed to offer a unified customer experience in each market. Actiste required robust, out-of-the-box connectivity anywhere it might be used. It was also crucial that the data gathering and sharing was secure and in compliance with local and global regulations.